Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut-Offs to Use?
Chronic liver diseases (CLDs) are a public health problem, even if frequently they are underdiagnosed. Hepatic steatosis (HS), encountered not only in nonalcoholic fatty liver disease (NAFLD) but also in chronic viral hepatitis, alcoholic liver disease, etc., plays an important role in fibrosis prog...
Saved in:
Main Authors: | Roxana Sirli, Ioan Sporea |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2021/6662760 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
by: V. P. Kovyazina, et al.
Published: (2021-04-01) -
Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
by: Ivana Mikolasevic, et al.
Published: (2021-01-01) -
Impact of liver graft steatosis on long-term post-transplant hepatic steatosis and fibrosis via magnetic resonance quantification
by: Lung-Yi Mak, et al.
Published: (2025-01-01) -
Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
by: Sumitro Kosasih, et al.
Published: (2018-01-01) -
Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
by: Sorim Choung, et al.
Published: (2018-01-01)